Cyclo Therapeutics Inc (CYTH)
0.74
+0.02
(+3.29%)
USD |
NASDAQ |
Nov 08, 11:00
Cyclo Therapeutics Revenue (Annual): 1.076M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.076M |
December 31, 2022 | 1.376M |
December 31, 2021 | 1.586M |
December 31, 2020 | 0.9034M |
December 31, 2019 | 1.007M |
December 31, 2018 | 1.012M |
December 31, 2017 | 1.238M |
December 31, 2016 | 1.503M |
December 31, 2015 | 0.9505M |
December 31, 2014 | 1.567M |
December 31, 2013 | 1.693M |
December 31, 2012 | 1.045M |
Date | Value |
---|---|
December 31, 2011 | 1.032M |
December 31, 2010 | 0.8024M |
December 31, 2009 | 0.6239M |
December 31, 2008 | 0.4949M |
December 31, 2007 | 0.7512M |
December 31, 2006 | 0.5423M |
December 31, 2005 | 0.4544M |
December 31, 2004 | 0.4647M |
December 31, 2003 | 0.3945M |
December 31, 2002 | 0.5224M |
December 31, 2001 | 0.2894M |
December 31, 2000 | 0.3472M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.9034M
Minimum
2020
1.586M
Maximum
2021
1.190M
Average
1.076M
Median
2023
Revenue (Annual) Benchmarks
Stryker Corp | 20.50B |
Biogen Inc | 9.836B |
Pfizer Inc | 58.50B |
Pacira BioSciences Inc | 674.98M |
Moderna Inc | 6.754B |